Literature DB >> 34224949

The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases.

Rasoul Mirzaei1, Farhad Zamani2, Marzieh Hajibaba2, Ashkan Rasouli-Saravani3, Mina Noroozbeygi3, Melika Gorgani4, Seyed Reza Hosseini-Fard5, Saba Jalalifar6, Hossein Ajdarkosh2, Seyed Hassnan Abedi7, Hossein Keyvani8, Sajad Karampoor9.   

Abstract

Exosomes are a nano-vesicle surrounded by a bilipid layer that can release from almost all cells and could be detected in tissues and biological liquids. These vesicles contain lipids, proteins, and nucleic acids (including DNA, mRNA, and miRNA) inside and on the exosomes' surface constitute their content. Exosomes can transfer their cargo into the recipient cell, which can modify recipient cells' biological activities. Recently it has been deciphering that the miRNA pattern of exosomes reveals the cellular pathophysiological situation and modifies various biological processes. Increasing data regarding exosomes highlights that the exosomes and their cargo, especially miRNAs, are implicated in the pathophysiology of various disorders, such as autoimmune disease. The current evidence on the deciphering of mechanisms in which exosomal miRNAs contributed to autoimmunity was indicated that exosomal miRNA might hold information that can reprogram the function of many of the immune cells involved in autoimmune diseases' pathogenesis. In the present study, we summarized the pathogenic role of exosomal miRNAs in several autoimmune diseases, including myasthenia gravis (MG), psoriasis, inflammatory bowel disease (IBD), type 1 diabetes (T1D), multiple sclerosis (MS), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjogren's Syndrome (SS), systemic sclerosis (SSc), vitiligo, and autoimmune thyroid diseases (AITD). Moreover, in this work, we present evidence of the potential role of exosomal miRNAs as therapeutic and diagnostic agents in autoimmune diseases.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Autoimmune diseases; Exosomal miRNAs; Exosomes; Inflammation; Pathogenic

Mesh:

Substances:

Year:  2021        PMID: 34224949     DOI: 10.1016/j.jneuroim.2021.577640

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

Review 1.  Immunometabolism in biofilm infection: lessons from cancer.

Authors:  Rasoul Mirzaei; Niloofar Sabokroo; Yaghoub Ahmadyousefi; Hamid Motamedi; Sajad Karampoor
Journal:  Mol Med       Date:  2022-01-29       Impact factor: 6.354

Review 2.  Molecular Basis for Paradoxical Activities of Polymorphonuclear Neutrophils in Inflammation/Anti-Inflammation, Bactericide/Autoimmunity, Pro-Cancer/Anticancer, and Antiviral Infection/SARS-CoV-II-Induced Immunothrombotic Dysregulation.

Authors:  Tsai-Hung Wu; Song-Chou Hsieh; Tsu-Hao Li; Cheng-Hsun Lu; Hsien-Tzung Liao; Chieh-Yu Shen; Ko-Jen Li; Cheng-Han Wu; Yu-Min Kuo; Chang-Youh Tsai; Chia-Li Yu
Journal:  Biomedicines       Date:  2022-03-25

Review 3.  Progress of exosome research in systemic lupus erythematosus.

Authors:  Jie Shen; Mengyu Zhang; Meiyu Peng
Journal:  Cytokine X       Date:  2022-05-21

Review 4.  microRNAs in human brucellosis: A promising therapeutic approach and biomarker for diagnosis and treatment.

Authors:  Sima Kazemi; Rasoul Mirzaei; Mohammad Sholeh; Sajad Karampoor; Fariba Keramat; Massoud Saidijam; Mohammad Yousef Alikhani
Journal:  Immun Inflamm Dis       Date:  2021-08-27

5.  A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis.

Authors:  Samantha Rodríguez-Muguruza; Antonio Altuna-Coy; Sonia Castro-Oreiro; Maria José Poveda-Elices; Ramon Fontova-Garrofé; Matilde R Chacón
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

6.  miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9.

Authors:  Qiang Wang; Yunquan Liu; Shixiang Kuang; Ruozhao Li; Ning Weng; Zhichao Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-09       Impact factor: 2.629

7.  Circulating Vitreous microRNA as Possible Biomarker in High Myopic Eyes with Macular Hole.

Authors:  Yoshimasa Ando; Hiroshi Keino; Makoto Inoue; Kazunari Hirota; Hiroyuki Takahashi; Kimihiko Sano; Takashi Koto; Tomohito Sato; Masaru Takeuchi; Akito Hirakata
Journal:  Int J Mol Sci       Date:  2022-03-26       Impact factor: 5.923

Review 8.  Role of genetic variants and host polymorphisms on COVID-19: From viral entrance mechanisms to immunological reactions.

Authors:  Abolfazl Adli; Mandana Rahimi; Reza Khodaie; Niloofar Hashemzaei; Sayed M Hosseini
Journal:  J Med Virol       Date:  2022-02-08       Impact factor: 20.693

Review 9.  The deciphering of the immune cells and marker signature in COVID-19 pathogenesis: An update.

Authors:  Saade Abdalkareem Jasim; Roaa Salih Mahdi; Dmitry Olegovich Bokov; Mazin A A Najm; Guzal N Sobirova; Zarnigor O Bafoyeva; Ahmed Taifi; Ola Kamal A Alkadir; Yasser Fakri Mustafa; Rasoul Mirzaei; Sajad Karampoor
Journal:  J Med Virol       Date:  2022-07-23       Impact factor: 20.693

Review 10.  Exosomes as Crucial Players in Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Yue Fei; Qi Liu; Na Peng; Guocan Yang; Ziwei Shen; Pan Hong; Shengjun Wang; Ke Rui; Dawei Cui
Journal:  J Immunol Res       Date:  2022-07-20       Impact factor: 4.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.